An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.

Danay Saavedra HernándezAna Laura Añé-KouríNaivy SánchezLázaro Manuel FilgueiraJulio BetancourtCarlos HerreraLeniel MansoElibet ChávezArmando CaballeroCarlos HidalgoGeydi LorenzoMeylan CepedaCarmen ValenzuelaMayra RamosKalet LeónZaima MazorraTania Crombet

Published in: Immunity & ageing : I & A (2020)

CECMED IIC RD-EC 179, RPCEC00000311. Registered 4 May 2020 - Retrospectively registered, http://rpcec.sld.cu/ensayos/RPCEC00000311-Sp or http://rpcec.sld.cu/trials/RPCEC00000311-En.

Keyphrases

monoclonal antibody
coronavirus disease
sars cov
aqueous solution
early onset